Zscaler Unveils AI Innovations to Power the Industry’s Most Comprehensive Data Protection Platform
May 14, 2024 03:01 ET
|
Zscaler, Inc.
SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, announced multiple innovations to its AI Data Protection Platform that leverage the...
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
May 14, 2024 02:02 ET
|
Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
MKS Instruments Announces Pricing of Upsized Private Offering of $1.2 Billion of 1.25% Convertible Senior Notes
May 13, 2024 23:01 ET
|
MKS Instruments, Inc.
ANDOVER, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”) today announced the pricing of its offering of $1.2 billion aggregate principal amount of 1.25%...
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024 21:50 ET
|
Belite Bio, Inc
Tinlarebant is Belite Bio’s orally administered tablet intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related...
Infinera to Announce Preliminary Fiscal First Quarter 2024 Financial Results on May 14, 2024
May 13, 2024 21:00 ET
|
Infinera Corporation
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) announced today that it will release its preliminary financial results for the first quarter of fiscal 2024...
HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China
May 13, 2024 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a...
HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui
May 13, 2024 20:00 ET
|
HUTCHMED (China) Limited
— Almost half a million people diagnosed each year across the globe — — Collaboration based on synergistic potential of inhibiting angiogenesis and tumor-associated macrophages with HUTCHMED’s...
Rumble Files Second Lawsuit Against Google for Monopolistic and Anticompetitive Practices
May 13, 2024 18:56 ET
|
Rumble, Inc.
LONGBOAT KEY, Fla., May 13, 2024 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced that it has filed a second lawsuit against Google...
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of April 2024
May 13, 2024 18:15 ET
|
ArrowMark Financial Corp.
DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp., (NASDAQ: BANX) ("ArrowMark Financial"), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of April...
ARMLOGI HOLDING CORP. ANNOUNCES PRICING OF $8 MILLION INITIAL PUBLIC OFFERING
May 13, 2024 18:00 ET
|
Armlogi Holding Corp
WALNUT, CA, May 13, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive...